Peregrine Ventures is a dedicated healthcare fund based in Israel, committed to improving patients' quality of life by investing in and supporting life-changing healthcare opportunities. They bring together deep industry knowledge and a synergetic strategy, allowing their investment professionals to support portfolio companies in developing meaningful breakthroughs in healthcare. Peregrine operates as a multidisciplinary powerhouse, offering scientific creativity and execution of business, regulatory, and investment strategies for life science companies across various stages, from seed to advanced growth. The firm works closely with entrepreneurs and industry partners to provide the knowledge and tools necessary to bring groundbreaking medical technologies to market. Peregrine's investment strategy involves providing support to companies at every stage of their lifecycle. This includes early and mid-stage funds, an 'Incentive' Incubator for pre-seed and seed companies, and Peregrine Growth, a fund focused on more mature companies in their late-stage financing rounds before M&A or IPO. Their commitment to identifying, funding, and partnering with entrepreneurs aims to generate outstanding results in the healthcare sector.
Preferred startup development maturity for initial funding deployment.
Medical Devices, Pharmaceuticals, Biotechnology, Digital Health, Life Sciences
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...